Concepedia

Thomas Frogne

TF

Statistics

Publications

14

Citations

1.3K

H-Index

13

Active since

2005

Affiliations

Novo Nordisk (Denmark)(Current)

Danish Cancer Society

University of Copenhagen

Inserm

Austrian Academy of Sciences

Thomas Frogne is an author at Novo Nordisk (Denmark) specializing in life sciences, signal transduction, and cell signaling.

Publications per year

2005–2021

14

Publications

14

Artemisinins Target GABAA Receptor Signaling and Impair α Cell Identity

Jin Li, Tamara Casteels, Thomas Frogne et al. · Cell · 2016 · 377 citations · Full text

, , +14

MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes

Amin Ardestani, Federico Paroni, Zahra Azizi et al. · Nature Medicine · 2014 · 202 citations · Full text

, , +13

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

Thomas Frogne, Rikke Vicki Benjaminsen, Katrine Sonne‐Hansen et al. · Breast Cancer Research and Treatment · 2008 · 155 citations · Full text

, , +11

The EndoC-βH1 cell line is a valid model of human beta cells and applicable for screenings to identify novel drug target candidates

Violeta Georgieva Tsonkova, Fredrik Wolfhagen Sand, Xenia Asbæk Wolf et al. · Molecular Metabolism · 2017 · 137 citations · Full text

, , +17

Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth

Thomas Frogne, J.S. Jepsen, S. S. Larsen et al. · Endocrine Related Cancer · 2005 · 90 citations

, , +15

1–5 of 14